H. Lundbeck AS (OCSE:HLUN A)
kr 35.25 -0.4 (-1.12%) Market Cap: 40.94 Bil Enterprise Value: 38.94 Bil PE Ratio: 13.51 PB Ratio: 1.51 GF Score: 44/100

H Lundbeck A/S at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 07:00PM GMT
James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, and good evening. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, at the JPMorgan Healthcare Conference, it's my pleasure to introduce Deborah Dunsire, CEO of Lundbeck, for this presentation. So today, we're going to have a 20-minute presentation from Deborah and then 20 mines for questions straight after. And you can immediately start registering your questions. And the way you do that is you use the Q&A function associated with this presentation, and that's on the conference website. And then I'll be happy to read out your questions from there.

With that said, I'd like to welcome Deborah to the conference and look forward to the presentation.

Deborah Dunsire;S;President;CEO
H. Lundbeck A

/-&

Thank you, James, and thanks, everybody, for joining us today to talk about where we're at, at the time of JPMorgan and talking about driving sustainable profitable growth. Moving on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot